Last reviewed · How we verify

Phenylephrine-ketorolac — Competitive Intelligence Brief

Phenylephrine-ketorolac (Phenylephrine-ketorolac) competitive landscape: 0 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Combination sympathomimetic and NSAID. Area: Ophthalmology.

marketed Combination sympathomimetic and NSAID Alpha-1 adrenergic receptor (phenylephrine); COX-1/COX-2 (ketorolac) Ophthalmology Small molecule Live · refreshed every 30 min

Target snapshot

Phenylephrine-ketorolac (Phenylephrine-ketorolac) — Milton S. Hershey Medical Center. Phenylephrine-ketorolac is a combination drug that uses a sympathomimetic vasoconstrictor (phenylephrine) and a nonsteroidal anti-inflammatory agent (ketorolac) to reduce bleeding and inflammation during ophthalmic surgery.

Comparator set

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

DrugGenericSponsorPhaseClassTargetApproval / PDUFA
Phenylephrine-ketorolac TARGET Phenylephrine-ketorolac Milton S. Hershey Medical Center marketed Combination sympathomimetic and NSAID Alpha-1 adrenergic receptor (phenylephrine); COX-1/COX-2 (ketorolac)

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Combination sympathomimetic and NSAID class)

  1. Milton S. Hershey Medical Center · 1 drug in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Phenylephrine-ketorolac — Competitive Intelligence Brief. https://druglandscape.com/ci/phenylephrine-ketorolac. Accessed 2026-05-15.

Build your own brief

Pick any drug + add comparators: